Population-based detection of systolic and diastolic dysfunction with amino-terminal pro–B-type natriuretic peptide
Open Access
- 31 July 2006
- journal article
- Published by Elsevier BV in American Heart Journal
- Vol. 152 (5), 941-948
- https://doi.org/10.1016/j.ahj.2006.05.007
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The N-terminal Pro-BNP Investigation of Dyspnea in the Emergency department (PRIDE) studyThe American Journal of Cardiology, 2005
- Why We Don’t Know the Answer May Be More Important than the Specific QuestionClinical Chemistry, 2004
- Burden of Systolic and Diastolic Ventricular Dysfunction in the CommunityJAMA, 2003
- N-Terminal Pro-B–Type Natriuretic Peptide and Long-Term Mortality in Acute Coronary SyndromesCirculation, 2002
- Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart FailureNew England Journal of Medicine, 2002
- The Prognostic Value of B-Type Natriuretic Peptide in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2001
- Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrationsThe Lancet, 2000
- Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1European Heart Journal, 1999
- Neurohumoral Prediction of Benefit From Carvedilol in Ischemic Left Ventricular DysfunctionCirculation, 1999
- Attenuation of Compensation of Endogenous Cardiac Natriuretic Peptide System in Chronic Heart FailureCirculation, 1997